Sean Brynjelsen

Sean Brynjelsen

Chief Executive Officer at ETON PHARMACEUTICALS, INC.

Net worth: 45 M $ as of 2026-07-30

54 year
Health Technology
Consumer Services

Profile

Sean E.
Brynjelsen
is President, Chief Executive Officer & Director at Eton Pharmaceuticals, Inc. since 2017.
Formerly, Senior Vice President-Global Business Development at Akorn, Inc. from 2015 to 2016, and Executive Vice President-Business Development at Sagent Pharmaceuticals, Inc. from 2016 to 2017.
Education includes an MBA from the University of Notre Dame in 2006, an undergraduate degree from the University of Illinois in 1993, and a graduate degree from the University of Illinois in 1995.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-08-19 961,194 ( 3.51% ) 45 M $ 2026-07-30

Sean Brynjelsen active positions

CompaniesPositionStart
ETON PHARMACEUTICALS, INC. Chief Executive Officer 2017-05-31

Former positions of Sean Brynjelsen

CompaniesPositionEnd
SAGENT PHARMACEUTICALS INC Corporate Officer/Principal 2017-05-31
AKORN, INC. Chief Tech/Sci/R&D Officer 2014-02-06
See the detail of Sean Brynjelsen's experience

Training of Sean Brynjelsen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Sean Brynjelsen